Danaher (DHR) EBITDA Margin (2009 - 2026)
Danaher (DHR) posted quarterly EBITDA Margin of 17.99% for Q2 2026, up 519.0% year-over-year from 2.91% in Q2 2025, and down 20.35% quarter-over-quarter from 22.58% in Q1 2026.
Danaher (DHR) EBITDA Margin (2009 - 2026) Analysis & Trends
Danaher's EBITDA Margin history runs 18 years deep, the most recent figure standing at 17.99% for Q2 2026.
- In Q2 2026, EBITDA Margin rose 519.0% year-over-year to 17.99%; the TTM figure through Jun 2026 stood at 20.42% (up 203.0% YoY), while the FY2025 annual figure was 19.09%, down 128.0% from the prior year.
- EBITDA Margin for Q2 2026 stood at 17.99%, down from 22.58% in the prior quarter.
- The five-year high for EBITDA Margin was 29.59% in Q2 2022, with the low at 12.8% in Q2 2025.
- The 5-year median for EBITDA Margin is 21.88% (2024), against an average of 22.12%.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin soared 849 bps in 2022, then plunged 930 bps in 2023.
- Danaher's EBITDA Margin stood at 27.99% in 2022, then fell by 25 bps to 20.87% in 2023, then climbed by 4 bps to 21.8% in 2024, then climbed by 1 bps to 21.97% in 2025, then slipped by 18 bps to 17.99% in 2026.
- Business Quant data shows DHR's EBITDA Margin at 17.99% in Q2 2026, 22.58% in Q1 2026, and 21.97% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 10.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 17.99% |
| Mar 27, 2026 | 22.58% |
| Dec 31, 2025 | 21.97% |
| Sep 26, 2025 | 19.06% |
| Jun 27, 2025 | 12.80% |
| Mar 28, 2025 | 22.19% |
| Dec 31, 2024 | 21.80% |
| Sep 27, 2024 | 16.52% |
| Jun 28, 2024 | 20.34% |
| Mar 29, 2024 | 22.64% |
| Dec 31, 2023 | 20.87% |
| Sep 29, 2023 | 21.07% |
| Jun 30, 2023 | 19.67% |
| Mar 31, 2023 | 25.50% |
| Dec 31, 2022 | 27.99% |
| Sep 30, 2022 | 26.60% |
| Jul 1, 2022 | 28.97% |
| Apr 1, 2022 | 29.59% |
| Dec 31, 2021 | 30.48% |
| Oct 1, 2021 | 18.11% |